TAUNS Laboratories,Inc. (TYO:197A)

Market Cap	51.27B -3.0%
Revenue (ttm)	11.68B -40.6%
Net Income	2.11B -67.6%
EPS	19.74 -65.8%
Shares Out	106.59M
PE Ratio	24.37
Forward PE	12.74
Dividend	28.00 (5.79%)
Ex-Dividend Date	Jun 29, 2026

Volume	315,600
Open	487.00
Previous Close	484.00
Day's Range	481.00 - 489.00
52-Week Range	463.00 - 603.00
Beta	0.73
Analysts	Sell
Price Target	420.00 (-12.68%)
Earnings Date	Aug 13, 2026

About TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. The company also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. The company was founded in 1987 and is headquartered in Izunokuni, Japan.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1987
• Employees: 218
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 197A

Financial Performance

In fiscal year 2025, TAUNS Laboratories,Inc.'s revenue was 18.63 billion, an increase of 1.05% compared to the previous year's 18.43 billion. Earnings were 6.32 billion, an increase of 9.38%.

Analyst Summary

According to 2 analysts, the average rating for 197A stock is "Sell." The 12-month stock price target is ¥420, which is a decrease of -12.68% from the latest price.

Price Target

¥420

(-12.68% downside)

Analyst Consensus: Sell

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error